Latest developments in MUC1 immunotherapy

gan Taylor-Papadimitriou, Joyce, Burchell, Joy M., Graham, Rosalind, Beatson, Richard
Cyhoeddwyd yn Biochem Soc Trans (2018)

O-linked mucin-type glycosylation in breast cancer

gan Burchell, Joy M., Beatson, Richard, Graham, Rosalind, Taylor-Papadimitriou, Joyce, Tajadura-Ortega, Virginia
Cyhoeddwyd yn Biochem Soc Trans (2018)

Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.

gan Bäckström, Malin, Link, Thomas, Olson, Fredrik J, Karlsson, Hasse, Graham, Rosalind, Picco, Gianfranco, Burchell, Joy, Taylor-Papadimitriou, Joyce, Noll, Thomas, Hansson, Gunnar C
Cyhoeddwyd 2003

Models of Breast Morphogenesis Based on Localization of Stem Cells in the Developing Mammary Lobule

gan Honeth, Gabriella, Schiavinotto, Tommaso, Vaggi, Federico, Marlow, Rebecca, Kanno, Tokuwa, Shinomiya, Ireneusz, Lombardi, Sara, Buchupalli, Bharath, Graham, Rosalind, Gazinska, Patrycja, Ramalingam, Vernie, Burchell, Joy, Purushotham, Anand D., Pinder, Sarah E., Csikasz-Nagy, Attila, Dontu, Gabriela
Cyhoeddwyd yn Stem Cell Reports (2015)

Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype

gan Beatson, Richard, Graham, Rosalind, Grundland Freile, Fabio, Cozzetto, Domenico, Kannambath, Shichina, Pfeifer, Ester, Woodman, Natalie, Owen, Julie, Nuamah, Rosamond, Mandel, Ulla, Pinder, Sarah, Gillett, Cheryl, Noll, Thomas, Bouybayoune, Ihssane, Taylor-Papadimitriou, Joyce, Burchell, Joy M.
Cyhoeddwyd yn Commun Biol (2020)

Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer

gan McKenzie, Duncan R., Graham, Rosalind, Lechmere, Thomas, Domingo-Vila, Clara, Alaguthurai, Thanussuyah, Arman, Celeste, Pollock, Emily, Gousis, Charalampos, Kakkassery, Helen, Carpenter, Esme, Kurshan, Ashwini, Vidler, Jennifer, Kulasekararaj, Austin, Patten, Piers, North, Bernard V., Tree, Timothy, Doores, Katie J., Hayday, Adrian C., Irshad, Sheeba
Cyhoeddwyd yn Cancer Res Commun (2022)

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

gan Monin, Leticia, Laing, Adam G, Muñoz-Ruiz, Miguel, McKenzie, Duncan R, del Molino del Barrio, Irene, Alaguthurai, Thanussuyah, Domingo-Vila, Clara, Hayday, Thomas S, Graham, Carl, Seow, Jeffrey, Abdul-Jawad, Sultan, Kamdar, Shraddha, Harvey-Jones, Elizabeth, Graham, Rosalind, Cooper, Jack, Khan, Muhammad, Vidler, Jennifer, Kakkassery, Helen, Sinha, Shubhankar, Davis, Richard, Dupont, Liane, Francos Quijorna, Isaac, O'Brien-Gore, Charlotte, Lee, Puay Ling, Eum, Josephine, Conde Poole, Maria, Joseph, Magdalene, Davies, Daniel, Wu, Yin, Swampillai, Angela, North, Bernard V, Montes, Ana, Harries, Mark, Rigg, Anne, Spicer, James, Malim, Michael H, Fields, Paul, Patten, Piers, Di Rosa, Francesca, Papa, Sophie, Tree, Timothy, Doores, Katie J, Hayday, Adrian C, Irshad, Sheeba
Cyhoeddwyd yn Lancet Oncol (2021)